Weight Loss Drugs May Reduce Activity

New research reveals an unexpected downside to popular weight-loss drugs like Ozempic and Wegovy: users tend to move less after starting treatment, logging hundreds fewer steps and minutes of activity daily. Despite shrinking waistlines, these GLP-1 agonists may also cause muscle loss, undermining long-term health. Men and those with existing joint or muscle pain see the steepest declines, highlighting the need for proactive exercise strategies—not an afterthought—to ensure truly sustainable, healthy weight loss. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/582b5ec8a13cd283